BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7510090)

  • 1. [Donors blood screening and prevention of posttransfusion type C hepatitis in Japan].
    Yoshizawa H
    Uirusu; 1993 Dec; 43(2):315-21. PubMed ID: 7510090
    [No Abstract]   [Full Text] [Related]  

  • 2. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
    Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
    Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 8. HCV and blood transfusion.
    Reesink HW; van der Poel CL; Cuypers HT; Lelie PN
    Arch Virol Suppl; 1992; 4():241-3. PubMed ID: 1280507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of anti-HCV screening and posttransfusion hepatitis].
    Kiyokawa H
    Rinsho Byori; 1992 Sep; 40(9):925-8. PubMed ID: 1279246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH).
    Villa E; Melegari M; Ferretti I; Vecchi C; Scaglioni PP; De Palma M; Manenti F
    Arch Virol Suppl; 1992; 4():247-8. PubMed ID: 1450695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.
    Garson JA; Tedder RS; Briggs M; Tuke P; Glazebrook JA; Trute A; Parker D; Barbara JA; Contreras M; Aloysius S
    Lancet; 1990 Jun; 335(8703):1419-22. PubMed ID: 1972209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 17. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1998; (62):237-49. PubMed ID: 9507813
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C--screening of blood donations.
    Walsh TJ
    Ir Med J; 1991 Jun; 84(2):41-2. PubMed ID: 1716620
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.